img

Global Cell Therapy Manufacturing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cell Therapy Manufacturing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Cell Therapy Manufacturing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Therapy Manufacturing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Clinical and Commercial are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cell Therapy Manufacturing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Cell Therapy Manufacturing key companies include Merck, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva and Lonza, etc. Merck, Avantor, Cell Therapies are top 3 players and held % share in total in 2022.
Cell Therapy Manufacturing can be divided into Autologous and Allogenic, etc. Autologous is the mainstream product in the market, accounting for % share globally in 2022.
Cell Therapy Manufacturing is widely used in various fields, such as Clinical, Commercial and Pre-clinical,, etc. Clinical provides greatest supports to the Cell Therapy Manufacturing industry development. In 2022, global % share of Cell Therapy Manufacturing went into Clinical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cell Therapy Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Avantor
Cell Therapies
Thermo Fisher Scientific
Charles River Laboratories
Catalent
Bio-Techne
Cytiva
Lonza
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Novartis
Bristol-Myers Squibb
Gilead
WuXi AppTec
Pharmaron
Aldevron
Exothera
Segment by Type
Autologous
Allogenic

Segment by Application


Clinical
Commercial
Pre-clinical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cell Therapy Manufacturing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cell Therapy Manufacturing introduction, etc. Cell Therapy Manufacturing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Cell Therapy Manufacturing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Cell Therapy Manufacturing
1.1 Cell Therapy Manufacturing Market Overview
1.1.1 Cell Therapy Manufacturing Product Scope
1.1.2 Cell Therapy Manufacturing Market Status and Outlook
1.2 Global Cell Therapy Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Cell Therapy Manufacturing Market Size by Region (2018-2033)
1.4 Global Cell Therapy Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Cell Therapy Manufacturing Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Cell Therapy Manufacturing Market Size (2018-2033)
1.6.1 North America Cell Therapy Manufacturing Market Size (2018-2033)
1.6.2 Europe Cell Therapy Manufacturing Market Size (2018-2033)
1.6.3 Asia-Pacific Cell Therapy Manufacturing Market Size (2018-2033)
1.6.4 Latin America Cell Therapy Manufacturing Market Size (2018-2033)
1.6.5 Middle East & Africa Cell Therapy Manufacturing Market Size (2018-2033)
2 Cell Therapy Manufacturing Market by Type
2.1 Introduction
2.1.1 Autologous
2.1.2 Allogenic
2.2 Global Cell Therapy Manufacturing Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Cell Therapy Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Cell Therapy Manufacturing Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell Therapy Manufacturing Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Cell Therapy Manufacturing Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Cell Therapy Manufacturing Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Cell Therapy Manufacturing Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Cell Therapy Manufacturing Revenue Breakdown by Type (2018-2033)
3 Cell Therapy Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Clinical
3.1.2 Commercial
3.1.3 Pre-clinical
3.2 Global Cell Therapy Manufacturing Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Cell Therapy Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Cell Therapy Manufacturing Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell Therapy Manufacturing Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Cell Therapy Manufacturing Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Cell Therapy Manufacturing Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Cell Therapy Manufacturing Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Cell Therapy Manufacturing Revenue Breakdown by Application (2018-2033)
4 Cell Therapy Manufacturing Competition Analysis by Players
4.1 Global Cell Therapy Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2022)
4.3 Date of Key Players Enter into Cell Therapy Manufacturing Market
4.4 Global Top Players Cell Therapy Manufacturing Headquarters and Area Served
4.5 Key Players Cell Therapy Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Cell Therapy Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Cell Therapy Manufacturing Products, Services and Solutions
5.1.4 Merck Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Avantor
5.2.1 Avantor Profile
5.2.2 Avantor Main Business
5.2.3 Avantor Cell Therapy Manufacturing Products, Services and Solutions
5.2.4 Avantor Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Avantor Recent Developments
5.3 Cell Therapies
5.3.1 Cell Therapies Profile
5.3.2 Cell Therapies Main Business
5.3.3 Cell Therapies Cell Therapy Manufacturing Products, Services and Solutions
5.3.4 Cell Therapies Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Charles River Laboratories
5.5.1 Charles River Laboratories Profile
5.5.2 Charles River Laboratories Main Business
5.5.3 Charles River Laboratories Cell Therapy Manufacturing Products, Services and Solutions
5.5.4 Charles River Laboratories Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Charles River Laboratories Recent Developments
5.6 Catalent
5.6.1 Catalent Profile
5.6.2 Catalent Main Business
5.6.3 Catalent Cell Therapy Manufacturing Products, Services and Solutions
5.6.4 Catalent Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 Catalent Recent Developments
5.7 Bio-Techne
5.7.1 Bio-Techne Profile
5.7.2 Bio-Techne Main Business
5.7.3 Bio-Techne Cell Therapy Manufacturing Products, Services and Solutions
5.7.4 Bio-Techne Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Techne Recent Developments
5.8 Cytiva
5.8.1 Cytiva Profile
5.8.2 Cytiva Main Business
5.8.3 Cytiva Cell Therapy Manufacturing Products, Services and Solutions
5.8.4 Cytiva Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Cytiva Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Cell Therapy Manufacturing Products, Services and Solutions
5.9.4 Lonza Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 BIOCENTRIQ
5.10.1 BIOCENTRIQ Profile
5.10.2 BIOCENTRIQ Main Business
5.10.3 BIOCENTRIQ Cell Therapy Manufacturing Products, Services and Solutions
5.10.4 BIOCENTRIQ Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 BIOCENTRIQ Recent Developments
5.11 FUJIFILM Diosynth Biotechnologies
5.11.1 FUJIFILM Diosynth Biotechnologies Profile
5.11.2 FUJIFILM Diosynth Biotechnologies Main Business
5.11.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Products, Services and Solutions
5.11.4 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.12 Novartis
5.12.1 Novartis Profile
5.12.2 Novartis Main Business
5.12.3 Novartis Cell Therapy Manufacturing Products, Services and Solutions
5.12.4 Novartis Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Novartis Recent Developments
5.13 Bristol-Myers Squibb
5.13.1 Bristol-Myers Squibb Profile
5.13.2 Bristol-Myers Squibb Main Business
5.13.3 Bristol-Myers Squibb Cell Therapy Manufacturing Products, Services and Solutions
5.13.4 Bristol-Myers Squibb Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Bristol-Myers Squibb Recent Developments
5.14 Gilead
5.14.1 Gilead Profile
5.14.2 Gilead Main Business
5.14.3 Gilead Cell Therapy Manufacturing Products, Services and Solutions
5.14.4 Gilead Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Gilead Recent Developments
5.15 WuXi AppTec
5.15.1 WuXi AppTec Profile
5.15.2 WuXi AppTec Main Business
5.15.3 WuXi AppTec Cell Therapy Manufacturing Products, Services and Solutions
5.15.4 WuXi AppTec Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 WuXi AppTec Recent Developments
5.16 Pharmaron
5.16.1 Pharmaron Profile
5.16.2 Pharmaron Main Business
5.16.3 Pharmaron Cell Therapy Manufacturing Products, Services and Solutions
5.16.4 Pharmaron Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.16.5 Pharmaron Recent Developments
5.17 Aldevron
5.17.1 Aldevron Profile
5.17.2 Aldevron Main Business
5.17.3 Aldevron Cell Therapy Manufacturing Products, Services and Solutions
5.17.4 Aldevron Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.17.5 Aldevron Recent Developments
5.18 Exothera
5.18.1 Exothera Profile
5.18.2 Exothera Main Business
5.18.3 Exothera Cell Therapy Manufacturing Products, Services and Solutions
5.18.4 Exothera Cell Therapy Manufacturing Revenue (US$ Million) & (2018-2023)
5.18.5 Exothera Recent Developments
6 North America
6.1 North America Cell Therapy Manufacturing Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cell Therapy Manufacturing Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell Therapy Manufacturing Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell Therapy Manufacturing Market Dynamics
11.1 Cell Therapy Manufacturing Industry Trends
11.2 Cell Therapy Manufacturing Market Drivers
11.3 Cell Therapy Manufacturing Market Challenges
11.4 Cell Therapy Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Cell Therapy Manufacturing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Cell Therapy Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Cell Therapy Manufacturing Market Size Share by Region (2018-2023)
Table 4. Global Cell Therapy Manufacturing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Cell Therapy Manufacturing Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Cell Therapy Manufacturing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Cell Therapy Manufacturing Revenue Market Share by Type (2018-2023)
Table 9. Global Cell Therapy Manufacturing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Cell Therapy Manufacturing Revenue Market Share by Type (2024-2033)
Table 11. North America Cell Therapy Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Cell Therapy Manufacturing Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Cell Therapy Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Cell Therapy Manufacturing Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Cell Therapy Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Cell Therapy Manufacturing Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Cell Therapy Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Cell Therapy Manufacturing Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Cell Therapy Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Cell Therapy Manufacturing Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Cell Therapy Manufacturing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Cell Therapy Manufacturing Revenue Market Share by Application (2018-2023)
Table 24. Global Cell Therapy Manufacturing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Cell Therapy Manufacturing Revenue Market Share by Application (2024-2033)
Table 26. North America Cell Therapy Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Cell Therapy Manufacturing Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Cell Therapy Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Cell Therapy Manufacturing Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Cell Therapy Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Cell Therapy Manufacturing Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Cell Therapy Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Cell Therapy Manufacturing Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Cell Therapy Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Cell Therapy Manufacturing Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Cell Therapy Manufacturing Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Cell Therapy Manufacturing Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2022)
Table 39. Date of Key Players Enter into Cell Therapy Manufacturing Market
Table 40. Global Cell Therapy Manufacturing Key Players Headquarters and Area Served
Table 41. Cell Therapy Manufacturing Product Solution and Service
Table 42. Global Cell Therapy Manufacturing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck Basic Information List
Table 45. Merck Description and Business Overview
Table 46. Merck Cell Therapy Manufacturing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Merck (2018-2023)
Table 48. Merck Recent Developments
Table 49. Avantor Basic Information List
Table 50. Avantor Description and Business Overview
Table 51. Avantor Cell Therapy Manufacturing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Avantor (2018-2023)
Table 53. Avantor Recent Developments
Table 54. Cell Therapies Basic Information List
Table 55. Cell Therapies Description and Business Overview
Table 56. Cell Therapies Cell Therapy Manufacturing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Cell Therapies (2018-2023)
Table 58. Cell Therapies Recent Developments
Table 59. Thermo Fisher Scientific Basic Information List
Table 60. Thermo Fisher Scientific Description and Business Overview
Table 61. Thermo Fisher Scientific Cell Therapy Manufacturing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Thermo Fisher Scientific (2018-2023)
Table 63. Thermo Fisher Scientific Recent Developments
Table 64. Charles River Laboratories Basic Information List
Table 65. Charles River Laboratories Description and Business Overview
Table 66. Charles River Laboratories Cell Therapy Manufacturing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Charles River Laboratories (2018-2023)
Table 68. Charles River Laboratories Recent Developments
Table 69. Catalent Basic Information List
Table 70. Catalent Description and Business Overview
Table 71. Catalent Cell Therapy Manufacturing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Catalent (2018-2023)
Table 73. Catalent Recent Developments
Table 74. Bio-Techne Basic Information List
Table 75. Bio-Techne Description and Business Overview
Table 76. Bio-Techne Cell Therapy Manufacturing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Bio-Techne (2018-2023)
Table 78. Bio-Techne Recent Developments
Table 79. Cytiva Basic Information List
Table 80. Cytiva Description and Business Overview
Table 81. Cytiva Cell Therapy Manufacturing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Cytiva (2018-2023)
Table 83. Cytiva Recent Developments
Table 84. Lonza Basic Information List
Table 85. Lonza Description and Business Overview
Table 86. Lonza Cell Therapy Manufacturing Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Lonza (2018-2023)
Table 88. Lonza Recent Developments
Table 89. BIOCENTRIQ Basic Information List
Table 90. BIOCENTRIQ Description and Business Overview
Table 91. BIOCENTRIQ Cell Therapy Manufacturing Products, Services and Solutions
Table 92. Revenue (US$ Million) in Cell Therapy Manufacturing Business of BIOCENTRIQ (2018-2023)
Table 93. BIOCENTRIQ Recent Developments
Table 94. FUJIFILM Diosynth Biotechnologies Basic Information List
Table 95. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 96. FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Products, Services and Solutions
Table 97. Revenue (US$ Million) in Cell Therapy Manufacturing Business of FUJIFILM Diosynth Biotechnologies (2018-2023)
Table 98. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 99. Novartis Basic Information List
Table 100. Novartis Description and Business Overview
Table 101. Novartis Cell Therapy Manufacturing Products, Services and Solutions
Table 102. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Novartis (2018-2023)
Table 103. Novartis Recent Developments
Table 104. Bristol-Myers Squibb Basic Information List
Table 105. Bristol-Myers Squibb Description and Business Overview
Table 106. Bristol-Myers Squibb Cell Therapy Manufacturing Products, Services and Solutions
Table 107. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Bristol-Myers Squibb (2018-2023)
Table 108. Bristol-Myers Squibb Recent Developments
Table 109. Gilead Basic Information List
Table 110. Gilead Description and Business Overview
Table 111. Gilead Cell Therapy Manufacturing Products, Services and Solutions
Table 112. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Gilead (2018-2023)
Table 113. Gilead Recent Developments
Table 114. WuXi AppTec Basic Information List
Table 115. WuXi AppTec Description and Business Overview
Table 116. WuXi AppTec Cell Therapy Manufacturing Products, Services and Solutions
Table 117. Revenue (US$ Million) in Cell Therapy Manufacturing Business of WuXi AppTec (2018-2023)
Table 118. WuXi AppTec Recent Developments
Table 119. Pharmaron Basic Information List
Table 120. Pharmaron Description and Business Overview
Table 121. Pharmaron Cell Therapy Manufacturing Products, Services and Solutions
Table 122. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Pharmaron (2018-2023)
Table 123. Pharmaron Recent Developments
Table 124. Aldevron Basic Information List
Table 125. Aldevron Description and Business Overview
Table 126. Aldevron Cell Therapy Manufacturing Products, Services and Solutions
Table 127. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Aldevron (2018-2023)
Table 128. Aldevron Recent Developments
Table 129. Exothera Basic Information List
Table 130. Exothera Description and Business Overview
Table 131. Exothera Cell Therapy Manufacturing Products, Services and Solutions
Table 132. Revenue (US$ Million) in Cell Therapy Manufacturing Business of Exothera (2018-2023)
Table 133. Exothera Recent Developments
Table 134. North America Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 135. North America Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 136. Europe Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 137. Europe Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 138. Asia-Pacific Cell Therapy Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 139. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 140. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2024-2033) & (US$ Million)
Table 141. Asia-Pacific Cell Therapy Manufacturing Market Share by Region (2018-2023)
Table 142. Asia-Pacific Cell Therapy Manufacturing Market Share by Region (2024-2033)
Table 143. Latin America Cell Therapy Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 144. Latin America Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 145. Latin America Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 146. Middle East & Africa Cell Therapy Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 147. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 148. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 149. Cell Therapy Manufacturing Market Trends
Table 150. Cell Therapy Manufacturing Market Drivers
Table 151. Cell Therapy Manufacturing Market Challenges
Table 152. Cell Therapy Manufacturing Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy Manufacturing Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Cell Therapy Manufacturing Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Cell Therapy Manufacturing Market Share by Regions: 2022 VS 2033
Figure 4. Global Cell Therapy Manufacturing Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Cell Therapy Manufacturing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Cell Therapy Manufacturing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Cell Therapy Manufacturing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Cell Therapy Manufacturing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Cell Therapy Manufacturing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Autologous
Figure 11. Global Autologous Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Allogenic
Figure 13. Global Allogenic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Cell Therapy Manufacturing Market Size Share by Type: 2022 & 2033
Figure 15. North America Cell Therapy Manufacturing Revenue Market Share by Type (2018-2033)
Figure 16. Europe Cell Therapy Manufacturing Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Cell Therapy Manufacturing Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Cell Therapy Manufacturing Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Cell Therapy Manufacturing Revenue Market Share by Type (2018-2033)
Figure 20. Clinical Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Commercial Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Pre-clinical Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Cell Therapy Manufacturing Market Size Share by Application: 2022 & 2033
Figure 24. North America Cell Therapy Manufacturing Revenue Market Share by Application (2018-2033)
Figure 25. Europe Cell Therapy Manufacturing Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Cell Therapy Manufacturing Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Cell Therapy Manufacturing Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Cell Therapy Manufacturing Revenue Market Share by Application (2018-2033)
Figure 29. Cell Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Cell Therapy Manufacturing Market Share in 2022
Figure 31. North America Cell Therapy Manufacturing Market Share by Country (2018-2033)
Figure 32. United States Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 35. France Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Cell Therapy Manufacturing Market Share by Region (2018-2033)
Figure 41. China Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 45. India Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Cell Therapy Manufacturing Market Share by Country (2018-2033)
Figure 48. Mexico Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Cell Therapy Manufacturing Market Share by Country (2018-2033)
Figure 51. Turkey Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Cell Therapy Manufacturing Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report